drugset / Trial / NCT06911866
A Phase Ib Study of RC1416 Injection
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a Phase Ib study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RC1416 injection in patients with moderate to severe asthma.
Timeline
- Start
- 2024-10-25
- Primary completion
- 2025-09-25
- Completion
- 2025-09-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RC1416 | Protein / enzyme biologic | — | Subcutaneous |